These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
153 related items for PubMed ID: 15162996
1. Demonstration of increased FDG activity in Rosai-Dorfman disease on positron emission tomography. Yu JQ, Zhuang H, Xiu Y, Talati E, Alavi A. Clin Nucl Med; 2004 Mar; 29(3):209-10. PubMed ID: 15162996 [No Abstract] [Full Text] [Related]
9. Positron emission tomography for the diagnosis of breast cancer. Rosé C, Dose J, Avril N. Nucl Med Commun; 2002 Jul; 23(7):613-8. PubMed ID: 12089482 [Abstract] [Full Text] [Related]
10. Rosai-Dorfman Disease of the Right Atrium Revealed by FDG PET/CT. Hou G, Pan Q, Cui R, Li F, Cheng W. Clin Nucl Med; 2020 Sep; 45(9):709-710. PubMed ID: 32701798 [Abstract] [Full Text] [Related]
11. The contribution of positron emission tomography (PET) with 18F-fluorodeoxyglucose (FDG) in the preoperative detection of axillary metastases of breast cancer: the experience of the National Cancer Institute of Milan. Crippa F, Agresti R, Donne VD, Pascali C, Bogni A, Chiesa C, De Sanctis V, Schiavini M, Decise D, Bombardieri E. Tumori; 1997 Sep; 83(2):542-3. PubMed ID: 9226015 [No Abstract] [Full Text] [Related]
12. Flare phenomenon in positron emission tomography in a case of breast cancer--a pitfall of positron emission tomography imaging interpretation. Tu DG, Yao WJ, Chang TW, Chiu NT, Chen YH. Clin Imaging; 2009 Sep; 33(6):468-70. PubMed ID: 19857808 [Abstract] [Full Text] [Related]
13. FDG PET/CT Image for a Rosai-Dorfman Disease With Pituitary and Bone Involvement in a Pediatric Patient. Kong Z, Wang Y, Ma W, Cheng X. Clin Nucl Med; 2019 Nov; 44(11):873-875. PubMed ID: 31584488 [Abstract] [Full Text] [Related]
14. Preoperative evaluation of prognosis in breast cancer patients by [(18)F]2-Deoxy-2-fluoro-D-glucose-positron emission tomography. Inoue T, Yutani K, Taguchi T, Tamaki Y, Shiba E, Noguchi S. J Cancer Res Clin Oncol; 2004 May; 130(5):273-8. PubMed ID: 14986112 [Abstract] [Full Text] [Related]
15. Spontaneous Recovery of Rosai-Dorfman Disease on FDG PET/CT. Xue Q, Miao W. Clin Nucl Med; 2017 Aug; 42(8):608-609. PubMed ID: 28525449 [Abstract] [Full Text] [Related]
16. Current and future use of positron emission tomography (PET) in breast cancer. Mankoff DA, Eubank WB. J Mammary Gland Biol Neoplasia; 2006 Apr; 11(2):125-36. PubMed ID: 17075687 [Abstract] [Full Text] [Related]
17. Rosai-Dorfman disease presenting as a breast mass and enlarged axillary lymph node mimicking malignancy: a case report and review of the literature. Tenny SO, McGinness M, Zhang D, Damjanov I, Fan F. Breast J; 2011 Apr; 17(5):516-20. PubMed ID: 21762247 [Abstract] [Full Text] [Related]
18. An Isolated Osseous Rosai-Dorfman Disease Shown on FDG PET/CT. Zadeh MZ, Wen Z, States LJ, Zhuang H. Clin Nucl Med; 2019 Jun; 44(6):485-488. PubMed ID: 30762829 [Abstract] [Full Text] [Related]
19. Fluorine-18 fluorodeoxyglucose imaging using dual-head coincidence positron emission tomography without attenuation correction in patients with head and neck cancer. Pai M, Park CH, Suh JH, Koh JH. Clin Nucl Med; 1999 Jul; 24(7):495-500. PubMed ID: 10402001 [Abstract] [Full Text] [Related]
20. PET imaging of Rosai-Dorfman disease: correlation with histopathology and ex-vivo beta-imaging. Menzel C, Hamscho N, Döbert N, Grünwald F, Kovács AF, Wolter M, Podda M. Arch Dermatol Res; 2003 Dec; 295(7):280-3. PubMed ID: 14566572 [Abstract] [Full Text] [Related] Page: [Next] [New Search]